rs1553821144
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PM5PP2PP3PP5_Very_Strong
The NM_006218.4(PIK3CA):c.1049A>G(p.Asp350Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D350N) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006218.4 missense
Scores
Clinical Significance
Conservation
Publications
- overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- megalencephaly-capillary malformation-polymicrogyria syndromeInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- vascular malformationInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden syndrome 5Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
PIK3CA related overgrowth syndrome Pathogenic:1
A PIK3CA c.1049A>G (p.Asp350Gly) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in multiple individuals with PIK3CA-Related Overgrowth Spectrum (PROS) disorders (Goss JA et al., PMID: 31909475; Zhang B et al., PMID: 37658401; Parker VER et al., PMID: 30270358; Gripp KW et al., PMID: 27191687). This variant has been reported in the ClinVar database as pathogenic in a germline state by a single submitter (ClinVar Variation ID: 521363) and it has also been reported in numerous cases in the cancer database COSMIC (Genomic Mutation ID: COSV55877939). This variant is absent from the general population (gnomAD v4.1.0), indicating it is not a common variant. The PIK3CA c.1049A>G (p.Asp350Gly) variant resides within the C2 domain of PIK3CA that is defined as a critical functional domain (Lai et al, PMID: 35997716). The PIK3CA gene is defined by the ClinGen Brain Malformations Variant Curation Expert Panel as a gene that has a low rate of benign missense variation and where missense variants are a common mechanism of disease (Lai et al, PMID: 35997716). Another variant in the same codon, c.1048G>A (p.Asp350Asn), has been reported and is considered pathogenic (ClinVar Variation ID: 418658). Based on available information and an internally developed protocol informed by the ACMG/AMP guidelines for variant interpretation and gene-specific practices from the ClinGen Criteria Specification Registry (Leon-Quintero FZ et al., PMID: 39434542), the PIK3CA c.1049A>G (p.Asp350Gly) variant is classified as pathogenic. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Inborn genetic diseases Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at